Kadioglu, A. Et Al. 2015. Re: Clinical Efficacy of Collagenase Clostridium histolyticum in the Treatment of Peyronie's Disease by Subgroups: Results from Two Large, Double-blind, Randomized, Placebo-controlled, Phase III Studies. EUROPEAN UROLOGY , vol.68, no.5 , 908-909.

Kadioglu, A., Boyuk, A., & Salabas, E., (2015). Re: Clinical Efficacy of Collagenase Clostridium histolyticum in the Treatment of Peyronie's Disease by Subgroups: Results from Two Large, Double-blind, Randomized, Placebo-controlled, Phase III Studies. EUROPEAN UROLOGY , vol.68, no.5, 908-909.

Kadioglu, Ateş, Abubekir Boyuk, And Emre SALABAŞ. "Re: Clinical Efficacy of Collagenase Clostridium histolyticum in the Treatment of Peyronie's Disease by Subgroups: Results from Two Large, Double-blind, Randomized, Placebo-controlled, Phase III Studies," EUROPEAN UROLOGY , vol.68, no.5, 908-909, 2015

Kadioglu, Ateş Et Al. "Re: Clinical Efficacy of Collagenase Clostridium histolyticum in the Treatment of Peyronie's Disease by Subgroups: Results from Two Large, Double-blind, Randomized, Placebo-controlled, Phase III Studies." EUROPEAN UROLOGY , vol.68, no.5, pp.908-909, 2015

Kadioglu, A. Boyuk, A. And Salabas, E. (2015) . "Re: Clinical Efficacy of Collagenase Clostridium histolyticum in the Treatment of Peyronie's Disease by Subgroups: Results from Two Large, Double-blind, Randomized, Placebo-controlled, Phase III Studies." EUROPEAN UROLOGY , vol.68, no.5, pp.908-909.

@article{article, author={Ateş KADIOĞLU Et Al. }, title={Re: Clinical Efficacy of Collagenase Clostridium histolyticum in the Treatment of Peyronie's Disease by Subgroups: Results from Two Large, Double-blind, Randomized, Placebo-controlled, Phase III Studies}, journal={EUROPEAN UROLOGY}, year=2015, pages={908-909} }